Safety and efficacy of adalimumab treatment in Japanese patients with psoriasis: Results of SALSA study

The safety and efficacy of adalimumab were evaluated over 24 weeks in Japanese patients with psoriasis in routine clinical practice. In this multicenter, observational, open‐label, postmarketing study, primary efficacy measures included the Psoriasis Area and Severity Index (PASI) and the Dermatolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Asahina, Akihiko, Torii, Hideshi, Ohtsuki, Mamitaro, Tokimoto, Toshimitsu, Hase, Hidenori, Tsuchiya, Tsuyoshi, Shinmura, Yasuhiko, Reyes Servin, Ofelia, Nakagawa, Hidemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108465/
https://www.ncbi.nlm.nih.gov/pubmed/27129439
http://dx.doi.org/10.1111/1346-8138.13409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108465/
https://www.ncbi.nlm.nih.gov/pubmed/27129439
http://dx.doi.org/10.1111/1346-8138.13409

Ejemplares similares